Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 4
1990 4
1991 17
1992 24
1993 23
1994 36
1995 26
1996 48
1997 42
1998 39
1999 33
2000 39
2001 40
2002 37
2003 45
2004 39
2005 45
2006 50
2007 34
2008 37
2009 41
2010 40
2011 35
2012 35
2013 47
2014 53
2015 45
2016 49
2017 63
2018 53
2019 55
2020 66
2021 74
2022 65
2023 61
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

1,318 results

Results by year

Filters applied: . Clear all
Page 1
Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
McCormack PL. McCormack PL. Am J Clin Dermatol. 2011 Dec 1;12(6):421-4. doi: 10.2165/11207670-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21967117 Review.
Calcipotriene (calcipotriol)/betamethasone dipropionate (calcipotriene 50 mug/g and betamethasone 0.5 mg/g) is a fixed-dose combination of a vitamin D3 analog and a corticosteroid indicated for the once-daily, topical treatment of psoriasis vulgaris of the tr
Calcipotriene (calcipotriol)/betamethasone dipropionate (calcipotriene 50 mug/g and betamethasone 0.5 mg/g) is a fixed-
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
Rosenberg AR, Tabacchi M, Ngo KH, Wallendorf M, Rosman IS, Cornelius LA, Demehri S. Rosenberg AR, et al. JCI Insight. 2019 Mar 21;4(6):e125476. doi: 10.1172/jci.insight.125476. eCollection 2019 Mar 21. JCI Insight. 2019. PMID: 30895944 Free PMC article. Clinical Trial.
However, the long-term effectiveness of calcipotriol plus 5-FU treatment for SCC prevention is unknown. METHODS: We performed a blinded prospective cohort study on participants of a randomized double-blind clinical trial in which a 4-day course of topical calcipotriol
However, the long-term effectiveness of calcipotriol plus 5-FU treatment for SCC prevention is unknown. METHODS: We performed a blind …
Drugs for psoriasis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Jun 17;61(1574):89-96. Med Lett Drugs Ther. 2019. PMID: 31381544 Review. No abstract available.
[Calcipotriol].
Guilhou JJ. Guilhou JJ. Ann Dermatol Venereol. 2001 Mar;128(3 Pt 1):229-37. Ann Dermatol Venereol. 2001. PMID: 11319386 Free article. Review. French.
Calcipotriol is a vitamin D derivative synthesized in 1985 by the Leo Laboratories. ...Therapeutic trials in psoriasis have demonstrated the superiority of Calcipotriol over its excipient, class 2 dermatocorticoids, and reducers. ...
Calcipotriol is a vitamin D derivative synthesized in 1985 by the Leo Laboratories. ...Therapeutic trials in psoriasis have de
The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
Thiers BH. Thiers BH. J Am Acad Dermatol. 1997 Sep;37(3 Pt 2):S69-71. J Am Acad Dermatol. 1997. PMID: 9344189 Review.
BACKGROUND: Topical calcipotriene ointment has been approved for the treatment of plaque-type psoriasis. ...RESULTS: Recent reports suggest that certain ichthyoses (particularly the hyperproliferative variants) and keratodermas may respond to topical calcipotriene o …
BACKGROUND: Topical calcipotriene ointment has been approved for the treatment of plaque-type psoriasis. ...RESULTS: Recent reports s …
Calcipotriol and psoriasis.
Ramsay CA. Ramsay CA. Int J Dermatol. 1992 Aug;31(8):549-50. doi: 10.1111/j.1365-4362.1992.tb02715.x. Int J Dermatol. 1992. PMID: 1428443 Review. No abstract available.
The Evolution of Topical Formulations in Psoriasis.
Kuehl B, Shear NH. Kuehl B, et al. Skin Therapy Lett. 2018 Jul;23(4):5-9. Skin Therapy Lett. 2018. PMID: 30086183 Free article. Review.
However, adherence to topical treatment remains a challenge, as the daily application creates a significant treatment burden. New topical therapeutic options need to offer higher efficacy and better patient acceptability, including easier application, to reduce treatment b …
However, adherence to topical treatment remains a challenge, as the daily application creates a significant treatment burden. New topical …
Epidermolysis bullosa: Advances in research and treatment.
Prodinger C, Reichelt J, Bauer JW, Laimer M. Prodinger C, et al. Exp Dermatol. 2019 Oct;28(10):1176-1189. doi: 10.1111/exd.13979. Epub 2019 Aug 8. Exp Dermatol. 2019. PMID: 31140655 Free PMC article. Review.
There is no cure for any of the subtypes of EB resulting from different mutations, and current therapy only focuses on the management of wounds and pain. Novel effective therapeutic approaches are therefore urgently required. Strategies include gene-, protein- and cell-bas …
There is no cure for any of the subtypes of EB resulting from different mutations, and current therapy only focuses on the management of wou …
Topical application of calcipotriene and corticosteroids: combination regimens.
Lebwohl M. Lebwohl M. J Am Acad Dermatol. 1997 Sep;37(3 Pt 2):S55-8. J Am Acad Dermatol. 1997. PMID: 9344186 Review.
BACKGROUND: Side effects of topical corticosteroids limit their long-term use. Calcipotriene/calcipotriol (Dovonex/Daivonex) ointment is not associated with any of the side effects of corticosteroids and has been shown to thicken the skin in contrast to the cutaneou …
BACKGROUND: Side effects of topical corticosteroids limit their long-term use. Calcipotriene/calcipotriol (Dovonex/Daivonex) o …
Non-psoriatic uses of calcipotriol: a concise updated review.
Patel RT, Gay JJ, Fagan KK, Eikenberg JD. Patel RT, et al. Dermatol Online J. 2023 Jun 15;29(3). doi: 10.5070/D329361422. Dermatol Online J. 2023. PMID: 37591262 Review.
Calcipotriol (calcipotriene) is a synthetic vitamin D3 derivative that is a standard treatment option for psoriasis. ...We surveyed the literature examining the use of calcipotriol for non-psoriatic dermatologic disease....
Calcipotriol (calcipotriene) is a synthetic vitamin D3 derivative that is a standard treatment option for psoriasis. ...We sur
1,318 results